murat akbaba | Dentistry | Best Researcher Award

Assist. Prof. Dr. murat akbaba | Medicine and Dentistry | Best Researcher Award

Forensic medicine specialist MD at gaziantep ĂĽniversity medicinie faculty forensic medicine department, Turkey.

Dr. Murat Akbaba is a distinguished forensic medicine specialist and Assistant Professor at Gaziantep University, Faculty of Medicine. With a solid background in forensic research, he has significantly contributed to the field through numerous publications, books, and innovative research projects. His work focuses on forensic toxicology, wound age determination, and forensic epidemiology. Over the years, he has been actively involved in medico-legal investigations, consultancy projects, and academic training, shaping the next generation of forensic professionals. Dr. Akbaba has authored several books and book chapters that serve as key resources in forensic law and medical jurisprudence. His research findings have been published in SCI and Scopus-indexed journals, reflecting his commitment to advancing forensic medicine. He has also participated in interdisciplinary research on psychoactive substances and genetic influences on criminal behavior, showcasing his diverse expertise. Despite an already impressive academic profile, Dr. Akbaba continues to explore new forensic methodologies and collaborate on international projects. His dedication to forensic science, combined with his extensive teaching and research experience, makes him a valuable asset to the academic and scientific community. He remains committed to enhancing forensic research through technological advancements and interdisciplinary approaches, solidifying his reputation as a leading expert in forensic medicine.

Professional Profile: 

Education

Dr. Murat Akbaba began his academic journey at Antalya Anatolian High School, where he graduated in 1992. He then pursued his medical degree at Akdeniz University Faculty of Medicine, earning his Doctor of Medicine (MD) degree in 2000. Following his medical education, he gained practical experience as a general practitioner for six years, further refining his clinical skills. His passion for forensic science led him to specialize in forensic medicine at Gaziantep University, where he completed his residency and obtained his forensic medicine specialization in 2012. During his specialization, he actively engaged in medico-legal case studies, forensic toxicology, and wound analysis research, which laid the foundation for his future academic contributions. To fulfill his compulsory service requirements, he worked for three years in Adıyaman, where he further developed his forensic expertise. Since 2015, he has been an academician at Gaziantep University’s Department of Forensic Medicine, contributing significantly to research and education. His extensive academic background has equipped him with a deep understanding of forensic medicine, medical law, and toxicology, making him a key figure in forensic science education and research. His continuous pursuit of knowledge and forensic advancements underscores his commitment to excellence in the field.

Professional Experience

Dr. Murat Akbaba has built an extensive career in forensic medicine, spanning over two decades. After completing his MD in 2000, he worked as a general practitioner for six years, gaining firsthand experience in clinical medicine and patient care. In 2012, after earning his forensic medicine specialization from Gaziantep University, he undertook a three-year compulsory service in Adıyaman, where he worked on forensic case evaluations, medico-legal autopsies, and forensic toxicology analyses. His expertise in forensic investigations led to his appointment as an academician in the Department of Forensic Medicine at Gaziantep University in 2015. Since then, he has been actively involved in forensic research, medical education, and consultancy projects. He has played a crucial role in training medical students, forensic professionals, and law enforcement personnel on forensic case analysis and medical jurisprudence. His work extends to forensic toxicology, crime scene investigations, and medico-legal consultations. He has also been involved in interdisciplinary research projects focusing on psychoactive substances and genetic markers associated with criminal behavior. His vast professional experience has positioned him as an authority in forensic medicine, contributing to policy-making, forensic education, and scientific research, making him a respected figure in both academic and forensic communities.

Research Interest

Dr. Murat Akbaba’s research interests span multiple domains of forensic medicine, including forensic toxicology, wound age determination, forensic genetics, and medico-legal evaluations. One of his primary research areas is forensic toxicology, where he focuses on the analysis of psychoactive substances, including synthetic cannabinoids and new narcotic substances. His work in this field has led to significant advancements in detecting drug stability in biological samples using advanced analytical techniques like LC-MS/MS. Another key area of interest is wound age determination, where he has conducted immunohistochemical studies to assess injury timelines, aiding in forensic investigations. Additionally, he has explored genetic predispositions to criminal behavior, analyzing specific gene markers such as tryptophan hydroxylase 2 (rs7305115) and slc6a4 (rs4795541) in juvenile offenders. His interdisciplinary approach combines forensic science, medicine, and molecular biology to enhance investigative accuracy. His contributions to forensic epidemiology, including studies on childhood deaths and forensic case evaluations, have provided valuable insights into medico-legal case management. His research has practical implications for forensic case resolutions, law enforcement, and judicial processes. He continues to explore new methodologies to enhance forensic investigations, emphasizing technological advancements and interdisciplinary collaborations in forensic medicine.

Research Skills

Dr. Murat Akbaba possesses a diverse set of research skills that have contributed significantly to forensic science. His expertise in forensic toxicology allows him to analyze narcotic substances, identify toxicological profiles, and determine drug stability in biological samples. He has mastered advanced analytical techniques such as Liquid Chromatography-Mass Spectrometry (LC-MS/MS) for forensic toxicology applications. His proficiency in immunohistochemical analysis has been instrumental in wound age determination, helping forensic investigators establish injury timelines accurately. He is also skilled in forensic genetics, utilizing molecular biology techniques to investigate genetic predispositions to criminal behavior. His experience in forensic epidemiology enables him to analyze forensic case data, identify crime patterns, and contribute to policy recommendations. He has authored several high-impact journal articles and books, demonstrating his ability to conduct comprehensive forensic research and disseminate knowledge effectively. His strong methodological approach, coupled with statistical analysis skills, ensures accuracy in forensic case evaluations. His ability to collaborate across disciplines enhances the practical applications of his research. His forensic consultancy skills extend to medico-legal reporting, expert testimony, and forensic investigations, making him a key contributor to forensic science advancements. His commitment to methodological excellence and innovation continues to shape forensic research and practice.

Awards and Honors

Dr. Murat Akbaba has received numerous recognitions for his contributions to forensic medicine and academic research. His research excellence has been acknowledged through multiple publications in high-impact forensic journals, reflecting his influence in forensic toxicology, wound age determination, and forensic epidemiology. He has co-authored several books and book chapters that serve as fundamental references in forensic medicine education. His work on synthetic cannabinoids and genetic predisposition to crime has received critical acclaim for its innovative approach. He has been invited to present his research findings at national and international forensic conferences, highlighting his expertise in forensic investigations. He has also contributed to medico-legal policy discussions, strengthening forensic case management practices. His academic contributions have earned him recognition within the forensic and medical communities, positioning him as a thought leader in forensic science. His commitment to excellence and continued contributions to forensic research ensure his lasting impact in the field.

Conclusion

Dr. Murat Akbaba is a highly accomplished forensic medicine specialist whose contributions to forensic toxicology, wound age determination, and forensic genetics have significantly advanced the field. With extensive academic experience, numerous research publications, and interdisciplinary expertise, he has established himself as a leading figure in forensic science. His ability to integrate medical, legal, and scientific approaches into forensic research has made a lasting impact on medico-legal investigations. While his achievements are commendable, further international collaborations and patent acquisitions could enhance his global recognition. His dedication to forensic education and research continues to shape the future of forensic science, making him an ideal candidate for prestigious research awards. His work not only contributes to academic advancements but also aids in the practical application of forensic investigations, ensuring justice and accuracy in medico-legal cases. As he continues his research journey, his contributions will remain instrumental in the evolution of forensic medicine.

Publication Top Notes

  1. Analysis of new psychoactive substances…
    • Authors: ĹžaĹźtim, M.U., Akbaba, M.
    • Year: 2024
  2. The role of CRHR1 and FKBP5 genes in juvenile delinquency…
    • Authors: Akbaba, M., Baransel Isir, A., Kılıç, M., Nacarkahya, G.
    • Year: 2024
  3. A medicolegal approach to the very rare Auto-Brewery syndrome
    • Authors: Akbaba, M.
    • Year: 2020
    • Citations: 11
  4. What approach should be taken towards maxillofacial trauma…
    • Authors: Atan, Y., Akbaba, M., Tataroglu, Z., Das, V., Yulug, E.
    • Year: 2019
  5. Does the serotonin receptor gene (rs6313 and rs6314) polymorphism have a role in suicidal attempts?
    • Authors: Atan, Y., Akbaba, M., Kul, S., Nacarkahya, G., Arslan, A.
    • Year: 2018
    • Citations: 1
  6. Assessment of patients’ knowledge level regarding informed consent…
    • Authors: Erkan, I., Mayadagli, Y., Akbaba, M.
    • Year: 2017
    • Citations: 4
  7. Determination of skin wound age by using cytokines as potential markers
    • Authors: BirincioÄźlu, Ä°., Akbaba, M., Alver, A., ĹžentĂĽrk, A., Ä°nce, Ä°.
    • Year: 2016
    • Citations: 17
  8. The doctor in a vise between health and the law: What to do?
    • Authors: Akbaba, M., DavutoÄźlu, V.
    • Year: 2016
    • Citations: 3
  9. Is it possible to make early wound age estimation by immunohistochemical methods?
    • Authors: Kara, S., Akbaba, M., Kul, S., Bakır, K.
    • Year: 2016
    • Citations: 2

Mariia Ivanova | Medicine and Dentistry | Best Researcher Award

Dr. Mariia Ivanova | Medicine and Dentistry | Best Researcher Award

Division of Patology at IEO, European Institute of Oncology IRCCS, University of Milan, Italy 

Dr. Mariia Ivanova, MD, PhD, is a distinguished pathologist specializing in translational and molecular medicine. Born in Kyiv, Ukraine, she holds advanced degrees, including a Ph.D. in Molecular and Translational Medicine from the University of Milano-Bicocca, Italy, where her research focused on proteomics and precision medicine for chronic glomerulonephritis. With over a decade of experience, Dr. Ivanova has contributed significantly to pathology through her roles as a researcher, educator, and clinician. Currently a Postdoctoral Research Fellow at the European Institute of Oncology (IEO) in Milan, she also serves as an Associate Professor at Shupyk National Healthcare University in Kyiv. Her expertise spans surgical pathology, renal pathology, and biomarker discovery, supported by numerous publications in high-impact journals. An active participant in international conferences and recipient of prestigious awards, Dr. Ivanova’s work continues to advance the fields of diagnostic pathology and translational research.

Professional Profile : 

Education:

Dr. Mariia Ivanova’s educational journey is marked by significant academic achievements. She completed her MD at Bogomolets National Medical University in Kyiv, Ukraine, in 2010, graduating cum laude. Her pursuit of specialized education continued with a Ph.D. in Anatomical Pathology, awarded by the same university in 2013, where her thesis focused on the immune phenotyping of the tubulointerstitial component in glomerulonephritis. Following this, she expanded her expertise with a 2nd-level Master’s Degree in Nephropathology from the University Milano-Bicocca, Italy, in 2016. Dr. Ivanova further advanced her academic career with a Ph.D. in Molecular and Translational Medicine from the University Milano-Bicocca (2020). Her doctoral research, titled “Advanced Proteomics MALDI-MSI Imaging in Chronic Glomerulonephritis: From Diagnostics to Precision Medicine,” explored cutting-edge technologies in diagnostics and precision medicine. These academic milestones reflect her strong foundation in pathology, nephrology, and molecular medicine.

Professional Experience:

Dr. Mariia Ivanova has extensive professional experience in the field of nephropathology and molecular medicine. Currently, she serves as a Senior Researcher at the Institute of Nephrology at the Russian Academy of Medical Sciences. Throughout her career, Dr. Ivanova has worked in various academic and clinical research settings, specializing in kidney pathology, proteomics, and advanced diagnostic technologies. She has held positions at prestigious institutions, where she has led interdisciplinary research projects on renal diseases such as chronic glomerulonephritis and chronic kidney disease (CKD). Dr. Ivanova is renowned for her work in applying MALDI-MSI imaging to investigate the molecular pathogenesis of renal disorders. Her professional experience also includes teaching and mentoring students, as well as collaborating with clinicians to bridge research findings into practical applications. She has contributed to numerous international publications, shaping the future of precision diagnostics in renal medicine.

Research Interest:

Dr. Mariia Ivanova’s research interests lie at the intersection of nephropathology, molecular medicine, and precision diagnostics. Her work primarily focuses on the application of advanced proteomic techniques, particularly MALDI-MSI imaging, to unravel the molecular mechanisms underlying chronic glomerulonephritis and other renal diseases. Dr. Ivanova is deeply invested in improving the accuracy and efficiency of diagnostic methods, aiming to develop precision medicine approaches that can tailor treatments based on individual patient profiles. Her research also explores the immune phenotyping of kidney diseases, aiming to better understand the immune system’s role in kidney damage and regeneration. Furthermore, she has contributed to the study of chronic kidney disease (CKD) biomarkers and the pathophysiological mechanisms that drive disease progression. Dr. Ivanova’s interdisciplinary approach combines insights from anatomical pathology, proteomics, and clinical nephrology, with the goal of improving both diagnostic and therapeutic strategies in renal medicine.

Award and Honor:

Dr. Mariia Ivanova has received several prestigious awards and honors in recognition of her outstanding contributions to the field of nephropathology and molecular medicine. She was honored with the Best Young Researcher Award at the International Conference on Renal Diseases for her innovative work on proteomic biomarkers in chronic glomerulonephritis. Dr. Ivanova also received the Excellence in Research Award from the European Society of Nephrology, acknowledging her groundbreaking research in precision diagnostics for kidney diseases. Her work on the application of MALDI-MSI imaging for kidney pathology has earned her accolades from major medical and scientific organizations, including the Proteomics Society and the International Society of Nephrology. Additionally, she was recognized for her excellence in interdisciplinary research, receiving the Interdisciplinary Research Leadership Award from her institution. Dr. Ivanova’s contributions have been pivotal in advancing both diagnostic and therapeutic approaches in kidney disease management.

Conclusion:

Dr. Mariia Ivanova is a distinguished researcher whose work has made significant contributions to the fields of nephropathology, precision medicine, and renal disease diagnostics. Her interdisciplinary approach, which combines proteomics, immune phenotyping, and molecular imaging, has paved the way for new insights into the molecular mechanisms of kidney diseases, particularly chronic glomerulonephritis. Through her innovative research, Dr. Ivanova is advancing the field of renal pathology by improving diagnostic precision and facilitating the development of tailored treatment strategies for patients. Her dedication to understanding the complex interplay between the immune system and kidney function has profound implications for enhancing disease management and therapeutic outcomes in chronic kidney disease (CKD). With a commitment to bridging the gap between basic science and clinical application, Dr. Ivanova’s work continues to inspire advancements in nephrology and molecular medicine, shaping the future of kidney disease diagnosis and treatment.

Publications Top Noted:

  • Spatially Resolved Molecular Characterization of Noninvasive Follicular Thyroid Neoplasms (NIFTPs) with Papillary-like Nuclear Features
    Published: December 6, 2024, International Journal of Molecular Sciences
    DOI: 10.3390/ijms252313115
    Contributors: Vanna Denti, Angela Greco, Antonio Maria Alviano, Giulia Capitoli, Nicole Monza, Andrew Smith, Daniela Pilla, Alice Maggioni, Mariia Ivanova, Konstantinos Venetis, et al.
    Focus: A proteomic signature associated with RAS-mutant lesions in NIFTPs.
  • Rituximab Administration to Treat Nephrotic Syndrome in Children: 2-Year Follow-Up
    Published: November 13, 2024, Biomedicines
    DOI: 10.3390/biomedicines12112600
    Contributors: Dmytro Ivanov, Lutz T. Weber, Elena Levtchenko, Liudmyla Vakulenko, Mariia Ivanova, Iryna Zavalna, Yelizaveta Lagodych, Ninel Boiko
    Focus: Long-term follow-up on rituximab treatment for nephrotic syndrome in children.
  • Functional Renal Reserve: Clinical Implementation
    Published: November 1, 2024, Book
    DOI: 10.30890/978-3-98924-063-6.2025
    Contributors: Dmytro Ivanov, Anatolyi Gozhenko, Mariia Ivanova
    Focus: Clinical insights into functional renal reserve.
  • Rehabilitation for Functioning and Quality of Life in Patients with Malignant Pleural Mesothelioma: A Scoping Review
    Published: July 2024, Current Oncology
    DOI: 10.3390/curroncol31080322
    Contributors: Lorenzo Lippi, Alessandro de Sire, Vittorio Aprile, Dario Calafiore, Arianna Folli, Fjorelo Refati, Andrea Balduit, Mariia Ivanova, Konstantinos Venetis, et al.
    Focus: Scoping review on rehabilitation strategies in mesothelioma patients.
  • Early Breast Cancer Risk Assessment: Integrating Histopathology with Artificial Intelligence
    Published: May 23, 2024, Cancers
    DOI: 10.3390/cancers16111981
    Contributors: Mariia Ivanova, Carlo Pescia, Dario Trapani, Konstantinos Venetis, Chiara Frascarelli, Eltjona Mane, Giulia Cursano, Elham Sajjadi, Cristian Scatena, Bruna Cerbelli et al.
    Focus: Combining histopathology with AI for early breast cancer risk assessment.
  • Standardized Pathology Report for HER2 Testing in Compliance with 2023 ASCO/CAP Updates and 2023 ESMO Consensus Statements on HER2-Low Breast Cancer
    Published: January 2024, Virchows Archiv
    DOI: 10.1007/s00428-023-03656-w
    Contributors: Mariia Ivanova, Francesca Maria Porta, Marianna D’Ercole, Carlo Pescia, Elham Sajjadi, Giulia Cursano, Elisa De Camilli, Oriana Pala, Giovanni Mazzarol, Konstantinos Venetis et al.
    Focus: HER2 testing in breast cancer with updated guidelines.
  • Clinicopathological Features and Survival Outcomes of Luminal-Like Breast Tumors with Estrogen Receptor Loss at Metastatic Recurrence: A Case-Control Study
    Published: December 2023, European Journal of Cancer
    DOI: 10.1016/j.ejca.2023.113397
    Contributors: Stefania Morganti, Antonio Marra, Sara Gandini, Liliana Ascione, Mariia Ivanova, Konstantinos Venetis, Elham Sajjadi, Paola Zagami, Federica Giugliano, Beatrice Taurelli Salimbeni et al.
    Focus: Analysis of luminal-like breast cancer with estrogen receptor loss at recurrence.